Related Experiment Videos
Thrombophilia and pregnancy
1Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel-Aviv Sourasky Medical Center, The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. tmcobgyn@tasmc.health.gov.il
Current Pharmaceutical Design
|March 22, 2005
Summary
Thrombophilia, a condition increasing clot risk, is linked to severe pregnancy complications like preeclampsia. Identifying thrombophilias may improve future pregnancy outcomes.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Genetics
Background:
- Preeclampsia, intrauterine growth restriction, and placental abruption are major causes of maternal and fetal mortality.
- Thrombophilia, an inherited or acquired condition, increases the risk of blood clots (thrombosis).
- Recent discoveries include inherited thrombophilias like factor V Leiden mutation, prothrombin mutation, and hyperhomocysteinemia, alongside acquired antiphospholipid antibodies.
Purpose of the Study:
- To explore the relationship between inherited and acquired thrombophilias and severe obstetric complications.
- To investigate the potential cause-and-effect link between thrombophilia and conditions like preeclampsia, intrauterine growth restriction, and placental abruption.
- To assess the therapeutic implications of thrombophilia testing in patients with these obstetric complications.
Main Methods:
- Review of existing literature on thrombophilia and obstetric complications.
- Analysis of pathological placental changes (placental vasculopathy) associated with adverse pregnancy outcomes.
- Correlation of identified thrombotic risks with clinical manifestations in pregnancy.
Main Results:
- Inherited thrombophilias (factor V Leiden, prothrombin mutation, hyperhomocysteinemia) and acquired thrombophilia (antiphospholipid antibodies) are associated with increased thrombosis risk.
- Placental vasculopathy, characterized by thrombotic changes, is linked to preeclampsia, intrauterine growth restriction, placental abruption, and fetal loss.
- A significant association suggests a causal relationship between thrombophilias and severe obstetric complications.
Conclusions:
- Inherited and acquired thrombophilias are strongly associated with severe obstetric complications.
- Testing for thrombophilias in affected patients may offer therapeutic benefits for subsequent pregnancies.
- Early identification and management of thrombophilia can potentially reduce maternal and fetal morbidity and mortality.